Marqeta Inc vs Synchrony Financial — how do they compare? Marqeta Inc trades at $18.11 (market cap $1.82B), while Synchrony Financial trades at $72.8 (market cap $23.99B). The key difference: Synchrony Financial is far larger — about 13.2× Marqeta Inc's market cap, and Synchrony Financial pays a 1.84% dividend while Marqeta Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Marqeta Inc for 44 Days and Synchrony Financial for 29 Days on average.
| MQ | SYF | |
|---|---|---|
Market Cap | $1.82B | $23.99B |
Volume | 1,126,466 | 3,813,027 |
Sector | Technology | Financials |
52-Week High | $20.32 | $88.47 |
52-Week Low | $15.04 | $63.78 |
Typical Hold Time | 44 Days | 29 Days |
Enterprise Value | $1.13B | $24.23B |
Dividend Yield | — | 1.84% |
Signals from Pluang's Aura AI — not financial advice
Marqeta (MQ) trades at $17.44, up 2.23% today, showing strong momentum after beating earnings expectations for three consecutive quarters. The stock displays a bullish technical outlook with positive moving average signals, though valuation metrics remain elevated with a P/E of 193.83. Recent partnerships with BVNK for stablecoin cards and Google for kids' wallets highlight ongoing business expansion despite mixed analyst sentiment.
MQ presents a high-risk, high-reward opportunity with improving fundamentals but premium valuation. Revenue growth has recovered from 2024 lows, and cash flow turned positive in 2025. However, the stock trades above most analyst targets, and contract renewals in Q3 2026 create near-term uncertainty. Investors should weigh growth potential against valuation concerns.
Synchrony Financial (SYF) trades at $73.72, up 2.49% on the day, with a bullish technical signal despite some bearish moving average indicators. The stock shows strong fundamentals with a low P/E of 7.56, robust net income margin of 23.4%, and consistent earnings beats in recent quarters. Recent developments include a partnership with OpenAI to enhance AI-driven shopping and expansion of CareCredit's veterinary financing via Vetspire, signaling growth initiatives.
The outlook remains positive given attractive valuation, high profitability, and analyst consensus price target of $87.58 implying ~19% upside. Key risks include rising credit delinquencies industry-wide and volatile cash flow trends, with net cash flow turning negative in 2026. Institutional sentiment is bullish with 61% buy ratings, but investors should monitor consumer spending resilience and Q3 2026 earnings due October 20.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
Read more on MQ →Synchrony Financial is a premier consumer financial services company and the largest provider of private-label credit cards in the United States. Spun off from GE Capital in 2014, it operates through a unique B2B2C model, embedding its financing products within the ecosystems of major partners like Amazon, Lowe’s, and PayPal. Synchrony leverages deep data analytics and a diverse multi-platform strategy—spanning retail, health, and auto—to drive customer loyalty and provide specialized credit solutions at the point of sale.
Read more on SYF →